Representative Work Representative Work

We work with clients across multiple industries and service areas on a full range of domestic and cross-border issues. Our leading team has acted on some of the most transformational transactions in Canada, the U.S. and around the world.

Results

Latest Work

Insolvency and Restructuring

Ernst & Young as court-appointed Monitor of the Zenabis group and its sale to SNDL

On November 1, 2022, in the context of its proceedings under the Companies' Creditors Arrangement Act (Canada), the Zenabis group announced its acquisition by its secured creditor SNDL, the largest private sector liquor and cannabis retailer in Canada, pursuant to an order of the Superior Court of...

Lead Office: Montreal Date Closed: -- Value: -

Read more
Mergers and Acquisitions

IniXium in its acquisition by NuChem

On October 31, 2022, NuChem Sciences, a Montréal-based contract research organization and leader in drug discovery, announced its acquisition of IniXium. This acquisition will allow NuChem to broaden its expertise in biological targets, also known as target proteins, whose manufacturing and...

Lead Office: Montreal Date Closed: -- Value: -

Read more
Emerging and High Growth Companies

Connektica in its $2.7 million seed round

On October 31, 2022, Connektica announced it had closed its $2.7 million seed round that saw participation from the National Research Council as well as Boreal Ventures, Space.VC, and the RAO Family Irrevocable Trust. With this funding, Connektica will expand and hire more staff. Connektica is a...

Lead Office: Montreal Date Closed: October 31, 2022 Value: $2.7 million

Read more
Emerging and High Growth Companies

OTI Lumionics in its $55 million Series B financing

On October 26, 2022, OTI Lumionics announced they had completed their Series B financing, led by Anzu Industrial Capital Partners, Samsung Ventures, and LG Technology Ventures. With this funding, OTI will be taking their “notch-free” tech into production with numerous partners,...

Lead Office: Toronto Date Closed: October 26, 2022 Value: $55 million

Read more
Mergers and Acquisitions

TELUS International in its US$1.225 billion acquisition of WillowTree

On October 27, 2022, TELUS International and TELUS Corporation announced they had entered into a definitive agreement to acquire WillowTree, a premier, full-service digital product provider focused on end user experiences, such as native mobile applications and unified web interfaces. Under...

Lead Office: Toronto Date Closed: -- Value: US$1.225 billion

Read more
Corporate and Commercial Disputes

Nieuport Aviation in obtaining a judgment of over $130 million against Porter Airlines in the case of Porter Airlines Inc. v. Nieuport Aviation

Osler acted for Nieuport Aviation, the owner of the terminal at Billy Bishop Toronto City Airport, in obtaining a judgment of over $130 million against Porter Airlines in the case of Porter Airlines Inc. v. Nieuport Aviation. This Commercial List trial was argued over a four-week period in late...

Lead Office: Toronto Date Closed: October 19, 2022 Value: $130 million

Read more
Emerging and High Growth Companies

Vendasta in its acquisition of Yesware

On October 18, 2022, Vendasta Technologies announced it had acquired Yesware, a private Boston-based company that offers a set of tools for sales teams to track email outreach activity and share that data across teams to drive better results. With this acquisition, Vendasta will bring...

Lead Office: Vancouver Date Closed: October 18, 2022 Value: -

Read more
Mergers and Acquisitions

Neptune Wellness Solutions in the $5.15M sale of its cannabis business to PurCann Pharma

On October 17, 2022, Neptune Wellness Solutions announced it had entered into a binding agreement to sell its cannabis business to PurCann Pharma Inc., a subsidiary of Groupe SiliCycle, a Quebec based company with over 27 years of experience with extracting and purifying active ingredients...

Lead Office: Montreal Date Closed: -- Value: $5.15 million

Read more
Emerging and High Growth Companies

Inversago Pharma in its $95 million Series C financing

On October 17, 2022, Inversago Pharma announced it had completed its $95 million Series C financing round led by New Enterprise Associates with participation from Forbion’s Growth Opportunities Fund, Amgen Ventures, Forbion’s Ventures Fund IV, Fonds de solidarité FTQ, Genesys...

Lead Office: Montreal Date Closed: October 17, 2022 Value: $95 million

Read more
Mergers and Acquisitions

VAALCO in its US$307 million business combination with TransGlobe

On October 14, 2022, VAALCO Energy completed its previously announced definitive arrangement agreement to acquire TransGlobe Energy in a stock-for-stock strategic business combination transaction valued at US$307 million. The combination of VAALCO and TransGlobe will create a world-class...

Lead Office: Toronto Date Closed: October 14, 2022 Value: US$307 million

Read more